Aimei Health Technology (AFJK) Return on Capital Employed (2024 - 2025)

Aimei Health Technology's (AFJK) quarterly Return on Capital Employed came in at 2.34% in Q3 2025, up 7.43% on a QoQ basis from 2.52% in Q2 2025.

Aimei Health Technology (AFJK) Return on Capital Employed (2024 - 2025) Analysis & Trends

Aimei Health Technology (AFJK) has 2 years of Return on Capital Employed data on file, last reported at 2.34% in Q3 2025.

On a quarterly basis, Return on Capital Employed changed N/A year-over-year to 2.34% in Q3 2025; TTM through Sep 2025 was 2.34%, a N/A change from a year earlier, with the FY2024 full-year figure at 1.49%, changed N/A from the prior year.
Return on Capital Employed for Q3 2025 stood at 2.34%, up from 2.52% in the prior quarter.
Over the last five years, Return on Capital Employed for AFJK reached as high as 1.47% in Q4 2024 and fell as low as 2.52% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	EQV Ventures Acquisition	480.75 Mn	480.75 Mn	-	-0.25%
2	Agriculture & Natural Solutions Acquisition	393.29 Mn	393.29 Mn	-	-1.55%
3	Berto Acquisition	314.56 Mn	314.35 Mn	-	-0.36%
4	GP-Act III Acquisition	313.66 Mn	313.66 Mn	-	-0.18%
5	Centurion Acquisition	311.65 Mn	311.65 Mn	-	-0.22%
6	Republic Digital Acquisition	310.50 Mn	309.63 Mn	-	-0.15%
7	Siddhi Acquisition Corp (Cayman Islands)	288.97 Mn	288.97 Mn	-	-3.13%
8	K&F Growth Acquisition	283.42 Mn	283.42 Mn	-	-0.25%
9	Bold Eagle Acquisition	275.29 Mn	275.29 Mn	-	-0.36%
10	Aimei Health Technology	48.57 Mn	48.57 Mn	-	-

Download Data